To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Participation

Driving Progress Against Childhood Cancer

Boys wearing soccer jerseys running

Childhood cancer is rare, yet about 11,050 children in the United States under the age of 15 will be diagnosed with cancer in 2020. While many types of cancers can appear in people of all ages, we know that kids are not just little adults and treatment often needs to be different. Pediatric clinical trials allow for the development of medicines with the unique needs of children in mind and have helped drive great strides against childhood cancer (1). Yet, there is still much more to learn and new advancements to be made.

Currently Lilly is working on an innovative approach to support advancing pediatric research by using master protocols to study new treatments for cancer patients. Master protocols are a novel way to study multiple research questions about several different drugs, diseases or conditions all in one clinical trial (instead of having to have multiple clinical trials) (2). Some of the potential benefits of this approach are to help to quickly test and answer scientific questions, compare different treatment options, reduce the cost of the study, reduce the time to set up new studies or enroll patients to aid in our ability to create medicines for our pediatric cancer patient population faster than we normally would under a non-master protocol clinical trial. 

An example of some of our master protocol clinical trials in pediatrics can be found at LillyTrialGuide.com with the heading in the title of the study "CAMPFIRE." CAMPFIRE stands for "Children’s and Young Adult Master Protocol for Innovative Pediatric Research." CAMPFIRE is a platform to accelerate the development of novel treatments for pediatric and young adult patients with cancer. This platform uses innovative designs and an overarching infrastructure to harness the benefits of shared data and operational efficiencies. The investigational agents on the trial will change over time based on the criteria established in the sub-protocols.

Explore the infographic below to learn more about the landscape of childhood cancer and the role of pediatric research in powering progress.

DrivingProgressAgainstChildhoodCancer Infographic 2Mar2020-01

Citations:

  1. https://www.cancer.gov/types/childhood-cancers
  2. J. Woodcock, L.M. LaVange. Master protocols to study multiple therapies, multiple diseases, or both. N. Engl. J. Med., 377 (2017), pp. 62-70

Blog post originally appeared on LillyPad.

Tags: Cancer, Infographic, Pediatric Research,

Recent Articles

WeMustIncreaseDiversityInClinicalTrials FeatureImage 24Feb2021-01

Paving the Way to Better Diversity in Clinical Trials

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
February 26th, 20218 minute read

To discuss what Lilly is doing to increase diversity in clinical trials, we spoke with two outstanding women who are leading the charge.

ResourcesToHelpAspiringClinicalResearchers FeatureImage 3Feb2021-01

Resources to Help Aspiring Clinical Researchers

Leigh Anne Naas Headshot
Leigh Anne Naas
February 10th, 20214 minute read

If you’re thinking about becoming a clinical researcher, it might be hard to know where to begin. We’ve outlined several resources to help you understand what to expect in a clinical research role.

StudyCoordinatorPatientPartnerThroughClinicalTrials FeatureImage 15Dec2020

Study Coordinator: Patient Partner Through Clinical Trials

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 13th, 20217 minute read

Study coordinators are a key part of the clinical trial journey. To learn more about what they do, read our interview with study coordinator, Kelly Roberts.

RandomizationInClinicalTrials FeatureImage 10Dec2020-01

Randomization in Clinical Trials

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
December 15th, 20206 minute read

What is randomization, and why do we use it in clinical research? Read more to uncover the answers to your questions.

CaringForCaregivers FeatureImage 17Nov2020

Caring for Caregivers

Susan Gilchrist headshot square
Susan Gilchrist
November 18th, 20204 minute read

Read more for services and support groups to make life a bit easier for caregivers - the unsung heroes in the clinical trial process.